Anti-obesity medications impacting the eye: An emerging concern - a narrative review

doi:10.5662/wjm.118520

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

(1)

(0)

(3)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Methodol. Sep 20, 2026; 16(3): 118520
Published online Sep 20, 2026. doi: 10.5662/wjm.118520

Open in New Tab Full Size Figure Download Figure

Figure 1 Shows three vertical pathways labelled “vascular”, “metabolic”, and “direct drug toxicity”, each leading to its respective mechanisms and anti-obesity drugs. GLP-1 RAs: Glucagon-like peptide-1 receptor agonists; NAAION: Non-arteritic anterior ischemic optic neuropathy.

Citation: Khullar S, Morya AK, Aggarwal S, Singh A, Sisodiya P, Morya R. Anti-obesity medications impacting the eye: An emerging concern - a narrative review. World J Methodol 2026; 16(3): 118520
URL: https://www.wjgnet.com/2222-0682/full/v16/i3/118520.htm
DOI: https://dx.doi.org/10.5662/wjm.118520

Khullar S, Morya AK, Aggarwal S, Singh A, Sisodiya P, Morya R. Anti-obesity medications impacting the eye: An emerging concern - a narrative review. World J Methodol 2026; 16(3): 118520 [DOI: 10.5662/wjm.118520]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.